Cardiomyopathies Clinical Trials

38 recruiting

Cardiomyopathies Trials at a Glance

46 actively recruiting trials for cardiomyopathies are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in London, New York, and Boston. Lead sponsors running cardiomyopathies studies include Imperial College London, First Affiliated Hospital Xi'an Jiaotong University, and Mayo Clinic.

Browse cardiomyopathies trials by phase

Treatments under study

About Cardiomyopathies Clinical Trials

Looking for clinical trials for Cardiomyopathies? There are currently 38 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiomyopathies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiomyopathies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 46 trials

Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesHeart Diseases+5 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting
Phase 3

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Heart FailureCardiomyopathiesMyocarditis+2 more
Niguarda Hospital80 enrolled10 locationsNCT06158698
Recruiting

Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy

Arrhythmogenic Cardiomyopathies
Nantes University Hospital80 enrolled5 locationsNCT05450783
Recruiting

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

CardiomyopathiesSudden Cardiac DeathCardiac Arrest+1 more
Idoven 1903 S.L.5,342 enrolled14 locationsNCT05890716
Recruiting
Phase 1

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

CardiomyopathiesFriedreich AtaxiaMyocardial Fibrosis+1 more
Weill Medical College of Cornell University25 enrolled1 locationNCT05302271
Recruiting
Phase 3

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled98 locationsNCT06563895
Recruiting

The Heart Hive - Cardiomyopathy Study

CardiomyopathiesMyocarditis
Imperial College London10,000 enrolled1 locationNCT04612296
Recruiting
Phase 4

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

CardiomyopathiesArrythmia
University of Rochester100 enrolled19 locationsNCT05034432
Recruiting

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

CardiomyopathiesValvular Heart DiseasePericardial Disease
Tulane University500 enrolled3 locationsNCT04843371
Recruiting

PKP2-ACM Natural History Study

CardiomyopathiesCardiovascular DiseasesHeart Diseases
Rocket Pharmaceuticals Inc.36 enrolled3 locationsNCT06644742
Recruiting

Mitochondrial Substrate Utilization in the Diabetic Human Heart

Heart FailureInsulin ResistanceMitochondrial Diseases+2 more
Heinrich-Heine University, Duesseldorf500 enrolled1 locationNCT05958706
Recruiting
Not Applicable

Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease

CardiomyopathiesArrhythmias, CardiacVentricular Tachycardia+1 more
Western Sydney Local Health District60 enrolled1 locationNCT06360939
Recruiting
Phase 2

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Heart FailureCardiomyopathiesCardiogenic Shock+1 more
Stanford University50 enrolled5 locationsNCT06080074
Recruiting

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

CardiomyopathiesArrhythmiaHeart Failure, Congestive+1 more
Johns Hopkins University1,500 enrolled4 locationsNCT00733590
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting
Not Applicable

High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study

Heart FailureCardiomyopathiesCardiac Conduction System+1 more
Miulli General Hospital34 enrolled1 locationNCT05491655
Recruiting
Phase 2Phase 3

Tailored Exercise Training Study Among Adults With HFpEF

Diabetic CardiomyopathiesHFpEF - Heart Failure With Preserved Ejection Fraction
University of Texas Southwestern Medical Center120 enrolled1 locationNCT07223242
Recruiting

Genetic Markers of Cardiovascular Disease in Epilepsy

CardiomyopathiesEpilepsySeizures+2 more
Mayo Clinic600 enrolled1 locationNCT02824822
Recruiting

Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy

Heart FailureCardiomyopathiesCardiovascular Diseases+2 more
Oslo University Hospital80 enrolled1 locationNCT05868616
Recruiting
Not Applicable

ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction

CardiomyopathiesVentricular ArrhythmiaLeft Ventricular Ejection Fraction Less Then or Equal to 50percent
University Hospital, Bordeaux210 enrolled3 locationsNCT07020702